the Botanical Synthesis PIONEERS
Revolutionizing Biologics
As a groundbreaking pioneer in the field of biologics, our proprietary Botanical Synthesis process technology enables the development and manufacturing of patentable plant-based small & complex molecules.
These innovative compositions, branded as BIOLOGICS+, deliver distinct advantages for the industry, including lower development and manufacturing costs, accelerated development timelines, and enhanced safety due to non-immunogenic properties.
In response to high demand, we have launched our Contract Development and Manufacturing Organization (CDMO) business unit, to allow industry partners to leverage our proprietary Botanical Synthesis process technology to address unmet needs in the pharmaceutical, nutraceutical, cosmeceutical, and nutrition sectors.
Nutrition
Nutraceuticals
Cosmeceuticals
Pharmaceuticals
AT THE CUTTING EDGE INERSECTION OF
HEALTH & WELLNESS
TECHNOLOGY & SUSTAINABILITY
HEALTH & WELLNESS An ageing population and a global movement of people looking for natural and plant-based solutions to improve their health.
OUR TECHNOLOGY Industry needs new technologies to provide clean, unique, patentable, fingerprint-consistent plant cell compositions.
SUSTAINABILITY Consumers are choosing to partner with companies that improve global sustainability and that prioritize ESG best practices.
Patents
Clinical Studies
Scientific Studies
Years R&D
Million Invested
We are a company at the nexus of several major trends
- An aging population and a global movement of people looking for natural and plant-based solutions to improve their health.
- Consumers are demanding that companies be responsible stewards of the environment, and are choosing to partner with companies that improve global sustainability, and that prioritize Environmental, Social and Governance best practices.
- Industry that is looking for new sources of clean, consistent, and novel health ingredients. Our technology delivers unique, patentable, fingerprint-consistent plant molecules and plant cell compositions with a fraction of the resource footprint of any alternative combination of agriculture and extraction.
***BioHarvest Sciences Now Trading on Nasdaq as Symbol “BHST”***
CEO Ilan Sobel and Chairman Dr. Zaki Rakib were interviewed November 7, 2024, to discuss the announcement that BioHarvest shares will begin trading on Nasdaq under the symbol “BHST” on Tuesday November 12. The company will continue to be listed on the Canadian Securities Exchange as “BHSC”.
The Botanical Synthesis Breakthrough
In 2007, Dr. Yochi Hagay and Dr. Zaki Rakib founded BioHarvest in Israel on the basis of a shared vision of marrying science with nature to improve human health. That Biotech journey started with developing a unique Botanical Synthesis platform technology that is capable of economically producing unique and consistent Botanical compositions to improve human health and wellness. This platform technology has been patented and trademarked as Bio-Plant Cellicitation™.
It’s first product (VINIA®) is based on red grape cells and is a full spectrum polyphenolic composition that includes an elicited (amplified) concentration of the powerful Piceid Resveratrol. VINIA® has undergone successful clinical trials and is already generating significant revenues. VINIA® represents a technological and commercial validation of Yochi and Zaki’s vision, and BioHarvest is developing additional novel botanical compositions and plant molecules in two complementary business units:
Product Business Unit– BioHarvest Sciences has built a playbook for commercial success with VINIA, and the same Direct to Consumer subscription strategies will be employed with future nutraceutical products under development.
CDMO Services – Pharmaceutical, Nutrition, Cosmeceutical, and Nutraceutical Industry partners can develop their own proprietary plant molecules and compositions. Successful commercialization of these compositions would result in BioHarvest Sciences producing the plant cell molecules under ongoing royalty or production agreements.
Revolutionizing Biologics: The Mind Behind the Once “Impossible”
OUR FIRST FLAGSHIP PRODUCT
VINIA, a proprietary red grape cell product containing the entire matrix of polyphenols contained in red grapes. Boost nitric oxide production, increasing the rate of blood flow. Enjoy more energy and circulation.
4.8 rating & over 50,000 customers
We encourage all of our customers to leave honest and uncensored feedback. Customers receive a 30-day supply when they submit a review, whether postive or negative.
Excellent!
“Can completely feel the difference between days I take Vinia in the morning vs those I don’t. Energy and focus through the day is a game changer.”
Gregory W
Great
“I suffer from cold hands and feet. With this product my hands and feet get warm. Which tells me that it’s helping my circulation.”
Alan H
Love it
“Been on Vinia for almost 2 months. I feel so much more energy, no urges to use caffeine at all since starting. I feel more alert right as soon as I wake up.”
Rob W
Feel Better
“Since I am in college, I have noticed better concentration and the ability to recall information better, than I was before I started taking this product.”
Bernise F
Back to the Future
As a company based on Science, we have already developed unique red grape cell compositions, and we are executing on a Clinical Trial roadmap that targets specific indications. Working with global partners on this research, we are testing compositions and dosages on a range of blood flow-related conditions, including brain and heart health, optic health, and sexual health.
As with our previous trials, results will steer our product roadmap, and we plan to launch additional BioHarvest-branded products with proven health benefits.
We have already proven our ability to market VINIA® to health-conscientious consumers, and we will expand our therapeutic product line – Olive and Pomegranate cell banks have already been developed, and the next generation of cell banks is under review.
The Pharmaceutical industry requires clean, consistent, and patentable compositions for Active Pharmaceutical Ingredients (APIs), and adjunct therapies. Our clinical trial and product development will not only generate superior present-day wellness products for consumers but our research is designed to align with potential future plant-based Pharma applications and research partnerships.
